Gene Query: HMOX1

Dataset Description Geneva Score
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 281.6
Zika infected neural stem cells 270.59
Transcriptome analysis of Zika infected neural stem cells 270.59
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 238.62
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 179.17
Statins modulate endothelial transcriptional profile by inhibiting EZH2 177.83
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 169.6
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 168.6
Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer 157.17
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 156.83
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 155.27
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 140.78
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 138.27
Identification of Nrf2 regulated genes by RNA sequencing 133.84
Nrf2 regulated genes in A549 cells 133.84
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 128.85
Transcriptome analysis in Neobractatin treated cells 116.47
MYCi361 regulates MYC target genes 116.46
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 2h] 112.3
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 107.89
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 107.86
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 105.63
Pharmacologic inhibition of STAT5 in AML 100.63
BAF controls genome accessibility 91.03
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 85.07
SUV420H2 knockdown in PANC-1 85.05
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 83.54
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 82.99
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 82.39
Anti-inflammatory effect of indoleacrylic acid (IA) 79.02
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 78.78
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 78.78
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 78.43
The effect of PPARG inhibition on human angiomyolipoma cells 78.21
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 78.0
MeRIP-seq for heat shock in B-cell lymphoma cells 75.54
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 73.88
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 72.9
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 70.87
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 69.59
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 68.52
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 65.22
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 65.14
Genetic-to-epigenetic Therapy for Pancreatic Cancer 64.79
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 63.47
circRNA-sequencing 63.41
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 63.11
RNA-seq of stable and unstable section of human atherosclerotic plaques 60.5
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 59.96
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 59.96
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 59.48
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 59.41
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 59.23
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 59.21
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 59.19
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 58.19
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 57.93
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 57.76
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 56.51
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 56.43
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 55.7
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 54.78
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 54.68
Genome-wide transcriptional response to random aneuploidy in human cells 53.83
Transcriptional change of THP-1 after HSV-1UL37WT or HSV-1UL37C819S 53.03
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 53.02
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 52.47
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 52.38
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 52.08
Tumor exosome integrins determine organotropic metastasis 51.82
EP400 is required for Max and MCPyV mediated gene activation 51.34
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 50.83
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 50.83
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 49.79
RNA-Sequencing of HepG2 cells treated with TGFBeta 49.38
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 49.24
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 48.55
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 48.4
Effect of disulfiram treatment on pediatric high grade glioma 48.25
Transcriptome analysis of kidney organoids 47.93
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 47.77
ZIKV infection of monocytes activates inflammasome pathways 47.75
RNA-seq in transgenic cells 47.6
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 46.73
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 46.02
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 45.62
Effect of from Human Umbilical Vein Endothelial Cells 45.11
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 44.81
TCF7L1 knockdown in pancreatic cancer 44.14
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 44.06
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 44.04
Identification of HOXB13 target genes responsive to BET inhibitors 43.39
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 43.23
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 43.06
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 42.65
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 42.64
Evolutionary origin and functional divergence of stem cell homeobox genes in eutherian mammals 42.39
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 42.1
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 42.1
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 42.01
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 41.86
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 41.42
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 41.11
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 40.92
SNHG5 siRNA knock down in HCT116 cells 40.62
Effect of hypoxia and TGFβ1 on gene expression in HPF fibroblast cells 40.61
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 40.51
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 40.03
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 39.63
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 39.17
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 24h] 38.96
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 38.84
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 38.66
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 38.66
Identification and Initial Functional Characterization of SENCR, a Long Non-Coding RNA Enriched in Human Vascular Cells 37.7
Nutritional control of protein translation 36.92
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 36.26
Co-transcriptional loading of RNA export factors shapes the human transcriptome 36.24
RNAseq of HEK293 cells after Chtop knockdown 36.24
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 35.75
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 35.63
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 35.61
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 35.49
Zone dependent distinctive gene expression profile of the normal human liver tissue 35.44
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 35.41
RNA-seq and Microarray in Transcriptome Profiling of Anterior Cruciate Ligament Tears: Implications for Prognostic Biomarkers Discovery 35.4
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 34.91
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 34.67
TGF-β regulation of miRNA expression in pancreatic cancer 34.64
Rorc disruption in human FG pancreatic cancer cells 34.36
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 34.35
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 34.27
Global Gene Expression Changes in Cholangiocytes Treated with TGF-beta 34.14
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 33.84
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 33.63
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 33.31
Characterization of parental and rociletinib-resistant derived H1975 cell lines 33.16
Iron response of HepG2 cells 33.1
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 33.09
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 33.01
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 32.91
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 32.7
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 32.64
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 32.64
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes (RNA-seq) 32.46
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes 32.46
High level DNA repair gene expression in human ES cells 32.02
Interferon-γ Converts Human Microvascular Pericytes into Negative Regulators of Alloimmunity through Induction of Indoleamine 2,3-Dioxygenase 1 31.56
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 31.15
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 31.15
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 30.77
PML2‐mediated thread‐like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome [RNA-seq] 30.7
PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome 30.7
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 30.32
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 30.25
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 29.99
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 29.9
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 29.9
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 29.76
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 29.73
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 29.58
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 29.46
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 29.39
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 29.24
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 29.12
RNA-sequencing in immortalized human mammary epithelial cells 29.12
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 28.89
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 28.72
ELP1 splicing correction reverses proprioceptive sensory loss in familial dysautonomia 28.69
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 28.67
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 28.61
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 28.51
RNA-seq analysis of BAP1-depleted uveal melanoma cells 28.28
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 28.27
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 28.23
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 28.07
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 28.07
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 28.0
RNAseq analysis of ESRP regulated splicing events in prostate cancer 27.88
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 27.86
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 27.71
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 27.39
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 27.32
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 27.32
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 26.92
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 26.89
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 26.77
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 26.76
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 26.6
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 26.53
oxLDL exposed trained monocytes 26.52
Transcriptomes of oxLDL exposed trained monocytes 26.52
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 26.21
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 26.14
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 26.14
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 25.8
RNAseq Analysis in glioblastoma cells treated with Mepazine 25.67
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 25.63
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 25.63
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 25.47
Multiple waves of transcriptome changes during extended hypoxic induction in human pulmonary microvascular endothelial cells 25.46
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 25.45
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 25.43
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 25.39
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 25.29
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 25.29
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 25.01
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 24.77
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 24.69
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 24.61
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 24.61
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 24.43
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 24.39
RNA-seq of MCF10A cells and CAF 24.26
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 24.15
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 24.07
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 23.82
The cytokine environment influence on human skin-derived T cells 23.78
Identification of a Cell-of-Origin for Fibroblasts Comprising the Fibrotic Reticulum in Idiopathic Pulmonary Fibrosis 23.72
A role for ZNF598 in post-transcriptional gene regulation 23.58
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 23.37
Paxillin regulates genomic networks in prostate cancer [LNCaP] 23.37
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 23.33
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 23.32
An RNA-centric dissection of host complexes controlling flavivirus infection 23.22
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 23.22
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 23.06
Gene Expression Profiling of SPOP Knocked Down Cell 23.02
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 22.98
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 22.96
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 22.96
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 22.81
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 22.69
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 22.69
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 22.68
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 22.54
A549 cell transcriptome responses to infection with H7N9 influenza virus 22.3
Transcriptome profiling of 5 human adenocarcinoma cell lines 21.91
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 21.89
Small-molecule targeting of brachyury transcription factor addiction in chordoma 21.82
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 21.61
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 21.35
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 21.31
TGF-β promotes genomic instability after loss of RUNX3 21.2
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins 21.01
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 20.83
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 20.76
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 20.76
Mechanistic Model-Guided Study of Embryonic Morphogenesis 20.69
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 20.67
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 20.67
RNA-seq analysis to identify the genes regulated by p53-SET interplay 20.61
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 20.45
KLF6-dependent transcription in renal cancer cells 20.41
Noncoding regions are the main source of targetable tumor-specific antigens 20.2
Effect of drugs on transcriptomic profiles 20.19
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 20.18
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 20.08
Gene expression profiling of KSHV-infected periodontal ligament cells 19.96
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 19.87
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 19.75
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 19.73
CircRNAome diversity in human mature B-cells, T-cells and monocytes 19.72
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 19.7
Safety profiling of genetically engineered Pim-1 kinase overexpression for oncogenicity risk in human c-kit+ cardiac interstitial cells 19.69
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 19.54
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 19.51
A transcriptome dataset revealing the molecular features of breast cancer stem cells 19.5
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 19.49
Investigation about fibroblasts of different origins in culture 19.44
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 19.39
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 19.36
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 19.35
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 19.35
HNRNPM-regulated splicing dependencies in prostate cancer 19.22
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 19.22
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 19.16
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 19.13
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 19.13
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 19.07
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 19.03
Transcriptome wide analysis of classically and alternatively activated macrophages 19.03
Transcriptome analysis of BAP1 knockout and restoration 18.84
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 18.84
A transcriptome-wide divergence in protein translation scales with LIN28B expression 18.83
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 18.83
The landscape of alternative splicing in aggressive prostate cancers 18.66
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 18.62
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 18.62
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 18.53
METTL3 promotes translation in human cancer cells 18.34
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 18.29
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 18.29
Tpl-2 small molecule project 18.15
Tpl-2 and MEK small molecule inhibitors 18.15
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 18.13
Effect of PRDM11 depletion in U2932 cells 17.92
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 17.85
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 17.67
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 17.48
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 17.42
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 17.29
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 17.09
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 17.03
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 17.0
Fibroblasts in cholesteatoma activate osteoclasts. 16.99
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 16.9
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 16.9
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 16.86
Transcriptomic profiling of human peripheral blood-derived mast cells 16.83
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 16.83
A novel non-canonical signaling pathway mediates TGF-β1-induced glucocorticoid insensitivity in epithelial cells 16.75
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 16.58
Redifferentiation of expanded human islet β cells by inhibition of ARX 16.49
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 16.26
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 16.26
ERBB3 and NGFR mark distinct skeletal muscle progenitor cells in human development enabling enrichment and maturation of hPSC muscle 16.25
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 16.11
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 15.88
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 15.87
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 15.67
Developmental stage specific chromosome architecture in human erythroid cells 15.67
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 15.65
Effect of FGF13 depletion on the H460 cell line 15.61
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 15.46
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 15.41
MicroRNA-125a-5p overexpression in human macrophages 15.15
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 15.01
Differential gene expression in Jagged1 treated human dental pulp cells. 14.89
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 14.8
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 14.72
Gene expression profile of multiple myeloma cell lines treated with CB-5083 14.7
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 14.69
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 14.55
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 14.54
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 14.46
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 14.46
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 14.46
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 14.45
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 14.4
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 14.04
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 13.96
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 13.93
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 13.87
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 13.85
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 13.57
Genome-wide analysis of Dengue virus 2 infected cells 13.54
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 13.54
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 13.49
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 13.41
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 13.37
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 13.32
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 13.17
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 13.16
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 13.02
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 12.96
RNA-seq analysis of differentiating human erythroblasts 12.87
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 12.86
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 12.59
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 12.59
RNA Seq of HMVEC under hypoxia 12.56
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 12.56
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 12.4
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 12.38
Global response to chemotherapy-induced apoptosis 12.35
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 11.93
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 11.89
The effect of insulin on mRNA transcription of human pluripotent stem cells 11.62
Transcriptomes of human monocytes after ex vivo exposure to uric acid 11.58
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 11.55
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 11.55
p63 controls the enhancer landscape during keratinocyte differentiation 11.33
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 11.3
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 11.3
RNA-seq analysis upon ARID1B overexpression 11.3
RNA-sequencing of human tendon after injury 11.27
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 11.24
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 11.24
Transcriptional profile in human S. haematobium infection 11.2
Transcriptome analysis reveals differential splicing events in IPF lung tissue 11.18
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 11.04
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 11.04
Multiple sclerosis and EAE 10.95
Human optic chiasm from healthy controls and multiple sclerosis patients 10.95
Transcriptional profile in dermal fibroblasts from patients with collagen VI related muscular dystrophy 10.86
Trascriptome of thyroid cancer-induced macrophages 10.8
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 10.78
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 10.64
Gene expression analysis in response to hypoxic pathway inhibition 10.4
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 10.26
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 10.26
Effects of human adipose tissue-derived and umbilical cord tissue-derived mesenchymal stem cells in a dextran sulfate sodium-induced mouse model 10.2
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 10.17
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 10.12
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 10.09
The role of CFTR in islet function 10.08
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 9.96
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 9.96
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 9.79
Metformin induces chromosome reorganization and changes in gene expression in normal human fibroblasts 9.74
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 9.69
Global gene expression differences between blood- and lymphatic-specific human dermal microvascular endothelial cells 9.65
Novel Atherogenic Pathways from the Differential Transcriptiome Analysis of Diabetic Epicardial Adipose Tissue 9.64
Aneuploidy-induced cellular stresses limit autophagic degradation. 9.38
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 9.28
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 9.28
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 8.96
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 8.8
Human Airway Smooth Muscle Transcriptome Changes in Response to Asthma Medications 8.71
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 8.7
Gene profiling of human adult and pediatric liver cancer cells 8.69
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 8.41
Regulation of poly(A) tail and translation during the somatic cell cycle 8.32
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 7.45
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 7.44
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 7.42
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 7.35
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 7.35
RNA expression profiles comparing primary and omental ovarian carcinoma samples 7.34
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells I 7.25
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 6.84
miR-93 Targets in Human Endothelial Cells 6.7
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 6.6
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 6.48
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 6.38
Transcriptomic analysis of ERR alpha orphan nuclear receptor 6.3
RNA-seq of naive and primed ES cells 6.21
The transcriptome of Kawasaki Disease arteritis 5.99
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 5.97
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 5.93
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 5.66
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 5.66
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 5.65
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 5.59
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  5.53
Transcriptome profiling of de-differentiated chondrocytes over-expressing miR-138 or miR-181ab1 during osteogenic induction 5.49
Gene expression profile of CRC-derived HILEC 5.42
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 5.15
Molecular Criteria for Defining the Naive Human Pluripotent State 5.09
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 5.06
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 4.89
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 4.78
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 4.78
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 4.75
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 4.61
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 4.42
NHLRC1 re-expression in cancer cells 4.23
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 4.13
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 4.03
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 4.02
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 3.94
Genome-wide transcriptome analysis of organotypic rafts derived from human papillomavirus type 16 infected primary keratinocytes [3D raft] 3.75
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 3.74
Characterisation of the EZH2 regulated transcriptome in de novo transformed cells (RNA-Seq) 3.72
Preclinical model of obesity and ER-positive breast cancer 3.69
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 3.23
Common inflammatory pathways between NEC and Crohn's disease 3.12
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 3.12
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 2.97
Next Generation Sequencing Facilitates Quantitative Analysis of Human Pluripotent Stem Cell-Derived Endocardial-like And Primary Cardiac Endothelial Cell Transcriptomes 2.94
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 2.94
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 2.86
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 2.77
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 2.75
Transcriptome profiling of A2M treated A549 Cell Line Samples 2.68
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 2.63
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 2.59
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 2.53
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 2.53
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells II 2.48
Alagille_Nodder 2.42
RNA Seq of Alagille liver biopsies 2.42
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 2.41
Transcriptome analyses of human pancreatic islets and pseudoislets 2.38
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells 2.37
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) 2.37
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 2.36
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 2.17
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 2.09
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 1.8
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 1.46
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 1.45
Expression patterns in chronic thromboembolic pulmonary hypertension 1.43
RNA-Seq analysis of breast cancer cells after shikonin treatment 1.34
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 1.32
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 1.18
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 1.09
Next Generation Sequencing of Lung Primary Fibroblast Responding to Eosinophil-Degranulation Products 0.89
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.88
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 0.86
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 0.84
Finding missing proteins from epigenetically manipulated human cells 0.72
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 0.64
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 0.47
Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders 0.41
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 0.4
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 0.4
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 0.39
A single cell reference map for human blood and tissue T cell activation 0.29
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 0.21


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation